The S&P 500 looks like it's in another "mania," according to a Stifel analysis examining 139 years of market history.

Barry Bannister, Stifel chief equity strategist, joins CNBC's 'Squawk on the Street' to discuss the economy, his analysis of ...

IBM set new highs this week and received a Buy rating from Stifel ahead of its upcoming third quarter financial results. Read ...

Stifel Financial Corp. (NYSE: SF) will release its third quarter 2024 financial results before the market opens on Wednesday, October 23, 2024. The company will host a conference call to review the ...

How can a firm supervise a broker when he’s got numerous text communications that have no visibility?” Jeff Erez asked.

ST. MARYS — Dickinson Center Inc. (DCI), a non-profit organization and affiliate of Journey Health System, announced a $5,000 ...

The case is one among many pending actions involving a structured note strategy overseen by broker Chuck Roberts.

Fintel reports that on October 14, 2024, Stifel downgraded their outlook for Kura Oncology (NasdaqGS:KURA) from Buy to Hold.

Stifel Nicolaus must pay roughly $14.2 million in damages, interest and fees to a Florida couple and a related family ...

The advisor at the center of the case, Chuck Roberts, has been the subject of at least 19 customer complaints since late 2022 ...

Stifel Financial Corp. saw its retail broker-dealer suffer a stunning loss of an lawsuit involving complex products and a ...

Oruka Therapeutics (ORKA) stock receives a buy rating from Stifel based on potential of its psoriasis candidates ORKA-001 and ORKA-002. Read more here.